Chinese english Germany Japanese Korea

31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz

31-O-[6-deoxy-4-O-(6-deoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, monosodium salt Struktur
82042-08-8
CAS-Nr.
82042-08-8
Bezeichnung:
31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz
Englisch Name:
31-O-[6-deoxy-4-O-(6-deoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, monosodium salt
Synonyma:
Einecs 279-891-5;31-o-(6-Deoxy-4-o-(6-deoxy-2,4-di-o-methylhexopyranosyl)-3-o-methylhexopyranosyl)-1-methylmocimycin, monosodium salt;31-O-[6-deoxy-4-O-(6-deoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, monosodium salt;2H-Pyran-2-acetamide, 4-[[6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-α-L-mannopyranosyl)-3-O-methyl-β-D-allopyranosyl]oxy]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-6-methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,4-dihydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadienyl]-α-ethyltetrahydro-2,3-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadienyl]-, monosodium salt;2H-Pyran-2-acetamide,4-[[6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-a-L-mannopyranosyl)-3-O-methyl-b-D-allopyranosyl]oxy]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-6-methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,4-dihydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadienyl]-a-ethyltetrahydro-2,3-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadienyl]-,monosodium salt (9CI)
CBNumber:
CB4892566
Summenformel:
C59H88N2NaO20+
Molgewicht:
1168.32119
MOL-Datei:
82042-08-8.mol
Request For Quotation

31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz Eigenschaften

Sicherheit

31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz Chemische Eigenschaften,Einsatz,Produktion Methoden

31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

31-O-[6-Desoxy-4-O-(6-desoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, Mononatriumsalz Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hu Bei Jiutian Bio-medical Technology CO.,Ltd 		027-88013699 17354350817
 Ryan@jiutian-bio.com China 7431 58
  • 31-O-[6-deoxy-4-O-(6-deoxy-2,4-di-O-methylhexopyranosyl)-3-O-methylhexopyranosyl]-1-methylmocimycin, monosodium salt
  • 31-o-(6-Deoxy-4-o-(6-deoxy-2,4-di-o-methylhexopyranosyl)-3-o-methylhexopyranosyl)-1-methylmocimycin, monosodium salt
  • Einecs 279-891-5
  • 2H-Pyran-2-acetamide,4-[[6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-a-L-mannopyranosyl)-3-O-methyl-b-D-allopyranosyl]oxy]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-6-methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,4-dihydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadienyl]-a-ethyltetrahydro-2,3-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadienyl]-,monosodium salt (9CI)
  • 2H-Pyran-2-acetamide, 4-[[6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-α-L-mannopyranosyl)-3-O-methyl-β-D-allopyranosyl]oxy]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-6-methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,4-dihydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadienyl]-α-ethyltetrahydro-2,3-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadienyl]-, monosodium salt
  • 82042-08-8
Copyright 2019 © ChemicalBook. All rights reserved